Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
major classes of antidepressants?
|
TCA
2nd/3rd generation AD SSRIs MAO-I |
|
cellular target of MAO-Is?
|
inhibit activity of MAO-A and to some extent MAO-B; MAO-A degrades NE and 5-HT; MAO-B degrades DA; results in increased amount of neurotransmitter in the presynaptic vesicle
|
|
what does MAO-A degrade?
|
NE, 5-HT
|
|
what does MAO-B degrade?
|
DA
|
|
seligilene (eldepryl)?
|
selective MAO-B inhibitor
|
|
phenylzine (nardil)?
|
irreversible inhibition of MAO-A and B
|
|
tranylcypromine (parnate)?
|
prolonged inhibition of MAO-A, but not irreversible
|
|
toxic effects of MAO-Is?
|
postural hypotension (secondary to desensitization of peripheral α receptors); insomnia, impotence (secondary to excessive autonomic activity); weight gain (uncertain); fatal hypertensive crisis (secondary to symphatomimetic amine ingestion); hyperpyrexia, convulsions (idiosyncratic administration of meperidine); serotonin syndrome (concomitant use of more than one antidepressant)
|
|
most important toxic effect of MAO-Is?
|
fatal hypertensive crisis secondary to sympathomimetic amine ingestion (tryamine, phenylpropanolamine, ephedrine)
|
|
what substances should be avoided with MAO-Is to avoid fatal hypertensive crisis?
|
tyramine, phenylpropanolamine, ephedrine
|
|
cellular target of TCA?
|
inhibit NE and/or 5-HT reuptake pumps causing an increase in synaptic concentrations
|
|
amitriptyline (elavil)?
|
TCA
|
|
imipramine (tofranil)?
|
TCA
|
|
toxicity and side effects of TCAs?
|
sympathomimetic: arrythmia, tremor, insomnia;
antihistaminic: initial sedation (developed tolerance after 1-2 weeks); antimuscarinic: dry mouth, blurred vision ,tachycardia, urinary retention; overdose: cardiac conduction defects |
|
which compound are TCAs chemically related to and what is the consequence?
|
phenothiazines --> retain some adrenergic, cholinergic, and histmine receptor blockade
|
|
which drugs enhance TCA effects by interfering with hepatic metabolism?
|
antipsychotics
methylphenidate |
|
which drugs reduce TCA effects by increasing hepatic metabolism?
|
barbiturates
|
|
TCA interact with which compounds to cause serotonin syndrome?
|
MAO-I
SSRIs |
|
general characteristics of second/third generation antidepressants?
|
inhibit 5-HT > NE reuptake, and have fewer promiscuous receptor blockage activity
|
|
which antidepressant has a unique mechanism?
|
mirtazipine: blocks 5-HT and α2 receptors
|
|
trazodone?
|
directly inhibit 5-HT receptors
inhibit 5-HT > NE reuptake |
|
side effects of trazodone?
|
priapism and drowsiness due to blockage of α1 and H1 receptors respectively
|
|
nefazodone?
|
directly inhibit 5-HT receptors
inhibit 5-HT > NE reuptake |
|
venlafaxine?
|
5-HT >> NE pump inhibition
some DA reuptake inhibition well tolerated effective in treatment of major depression and anxiety disorders |
|
bupropion (wellbutrin; zyban)?
|
unknown mechanism
weak inhibition of monoamine reuptake |
|
side effects and contraindications for bupropion?
|
dose-dependent increase in seizures;
contraindicated in patients taking zyban for smoking cessation and epileptics |
|
amoxapine?
|
metabolite of an antipsychotic (loxapine);
associated with extrapyramidal side effects |
|
maprotiline?
|
potent NE reuptake inhibitor;
few sedative side effects |
|
mirtazipine?
|
blocks 5-HT and α2 receptors (unique);
blocks H1 receptor causing sedation; significant weight gain |
|
SSRIs mechanism?
|
inhibition of 5-HT pump;
long half-life and active metabolites |
|
fluoxetine (prozac)?
|
SSRI
|
|
toxicity and side effects of SSRIs?
|
5-10% incidence of nausea, insomnia, anxiety, decreased libido, ED (secondary to excessive 5-HT, generally develop tolerance)
|
|
use of lithium?
|
preventing manic episodes; not used for acute treatment of manic phase
|
|
mechanism of action of lithium?
|
depress noradrenergic or serotonergic transmission by decreasing the formation of postsynaptic second messengers (inositol triphosphate and diacyllycerol)
|
|
what is lithium intoxication associated with?
|
sodium depletion: severe diarrhea, sweating, fever, low Na diet, thiazide diuretics, NSAIDs
|
|
side effects of lithium?
|
initial: GI irritation, muscular weakness, tremors, edema;
1.5-3 mEq/L: ataxia, drowsiness, muscle rigidity; 3 mEq/L: cardiac arrythmia, seizures, coma; nontoxic goiter; nephrogenic diabetes insipidus |
|
in what heart condition is lithium contraindicated?
|
sick sinus syndrome (depress sinus node)
|
|
drug interactions with lithium?
|
diuretics, particularly thiazides: Na depletion leads to Li retention;
NSAIDs: increase Li reabsorption |
|
general relationship of renal lithium excretion to sodium intake?
|
Na loading causes an increase in Li excretion whereas Na depletion causes Li retention
|